文献速递关节外科

融合髋转换为全髋关节置换术:长期临床与影像学结局

Conversion of Fused Hip to Total Hip Arthroplasty: Long-Term Clinical and Radiological Outcomes.
PubMed 文献 · J Arthroplasty · 2020-10-17

本研究评估57例患者(59髋)融合髋转换为全髋关节置换术后的长期临床与影像学结局,平均随访13.0±6.2年,Harris髋关节评分和视觉模拟评分均显著改善(均P<.001),假体生存率25年时为73.4±8.0%,但并发症率为29.8%,49.1%出现异位骨化。

要点

  • 融合髋转换为全髋关节置换术后长期随访Harris髋关节评分和视觉模拟评分均显著改善,均P<.001。
  • 平均随访13.0±6.2年,假体生存率5年98.7±1.3%、10年92.4±3.3%、15年82.1±5.7%、20年和25年均为73.4±8.0%。
  • 总体并发症率29.8%,异位骨化发生率49.1%,Trendelenburg征阳性率40.4%。

核心结论

  • 融合髋转换为全髋关节置换术在长期随访中提供高水平的髋关节功能和对手术的满意度。
  • 术后25年可预期假体生存率高于70%。

研究设计与样本

  • 研究纳入57例患者(59髋),评估融合髋转换为全髋关节置换术后的临床与影像学结局,最低随访5年。

主要发现

  • 平均随访13.0±6.2年,Harris髋关节评分从46.0±16.7改善至80.8±18.8(P<.001),视觉模拟评分从4.4±1.5改善至2.1±1.4(P<.001)。
  • 23例患者(40.4%)Trendelenburg征阳性,29例(49.1%)发现异位骨化,总体并发症率为29.8%。
  • 吸烟习惯和类风湿关节炎可预测Trendelenburg征(分别为P=.046和P=.038)。
  • 以假体生存率为终点,5年98.7±1.3%、10年92.4±3.3%、15年82.1±5.7%、20年和25年均为73.4±8.0%。
  • 既往髋部手术(定义为融合前任何髋部手术)患者累积假体生存率更差(P=.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite promising results at the mid-term followup, several aspects of conversion of the fused hip to total hip arthroplasty (THA) remain controversial. The aim of this study was to evaluate clinical and radiological outcomes with a minimum 5-year followup in patients who underwent conversion of the fused hip to THA. METHODS: Fifty-seven patients (59 hips) were evaluated. The Harris Hip Score (HHS), range of motion (ROM), and the Visual Analogue Scale (VAS) were used to assess hip function and low back pain. Subjective satisfaction with surgery and the presence of the Trendelenburg sign was also evaluated. Radiological assessment was performed pre- and postoperatively to evaluate loosening and heterotopic ossification (HO). RESULTS: After a mean followup of 13.0 ± 6.2 years, HHS and VAS significantly improved from 46.0 ± 16.7 to 80.8 ± 18.8 and from 4.4 ± 1.5 to 2.1 ± 1.4 (both P < .001), respectively. Twenty-three patients (40.4%) had a positive Trendelenburg sign, and HOs were found in 29 cases (49.1%). An overall 29.8% complication rate was noted. Smoking habits and rheumatoid arthritis were predictive of Trendelenburg sign (P = .046 and P = .038, respectively). Implant survival rate as the end point was 98.7 ± 1.3% at 5 years, 92.4 ± 3.3% at 10 years, 82.1 ± 5.7% at 15 years, and 73.4 ± 8.0% at 20 and 25 years. A worse cumulative implant survival rate was noted in patients who underwent previous hip surgery, defined as any hip operation before fusion (P = .005). CONCLUSION: Conversion of the fused hip to hip arthroplasty provides high levels of hip functionality and satisfaction with surgery at long-term followup. An implant survival rate higher than 70% can be expected 25 years postoperatively.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Grappiolo G, Bruno CF, Loppini M, et al. Conversion of Fused Hip to Total Hip Arthroplasty: Long-Term Clinical and Radiological Outcomes. J Arthroplasty. 2020. PMID: 33082070. doi:10.1016/j.arth.2020.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。